Chemours (CC) PT Lowered to $18 at Morgan Stanley
Tweet
Share
E-mailGet Alerts CC Hot Sheet
Price: $14.32 -0.83%
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 8 | New: 26
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 8 | New: 26
Join SI Premium – FREE
Morgan Stanley analyst Vincent Andrews lowered the price target on Chemours (NYSE: CC) to $18.00 (from $21.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Securitize Corp (SECZ) PT Raised to $12 at StoneX on 'Innovation Exemption'
- Lasertec Corp. (6920:JP) (LSRCF) PT Raised to JPY41,800 at Nomura/Instinet
- Polaris Industries (PII) PT Lowered to $61 at UBS, Neutral Rating Maintained
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
